Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Microbiome 2020

About Conference

With the enormous response from the previous International Conference on 3rd International Conference on Microbiome, Probiotics & Gut Nutrition(Microbiome 2019), Conference Series LLC LTD invites all the participants from all over the world to attend “4th International Conference on Microbiome, Probiotics & Gut Nutrition” during December 07-08, 2020 in Vancouver, Canada which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The theme of the conference is “Current Research on Microbiomes, probiotics and Biostimulants” The conference focus on major tracks as Human Microbiota, Prebiotics and Probiotics, Biostimulants and Biocontrol strategies, Gut Microbiota, Plant-growth promoting bacteria, Pediatric Microbiome, Bioinformatics for Microbiome, Microbiome in Epigentics & Epigenome etc. The scientific programme of the conference is broad and embraces different research aspects with focus on applied and advanced probiotics, and in particular with a microbiology and infectious diseases.  

Conference Name



Microbiome 2020

Vancouver, Canada

December 07-08, 2020

Why to Attend???

Microbiome 2020 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about microbiology research and its advances. This is your best opportunity to reach the largest assemblage of participants from microbiology community that is from academia, microbiology entities, medical groups, labs, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new clinical research developments, and receive name recognition at this 2-days event. World-renowned speakers and the most recent techniques, developments, the newest updates in Microbiome are hallmarks of this conference.

Who Should Attend?

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

  • Microbiology Research Sites
  • Pathologists and Immunologists
  • Research Scientists
  • Pharma/Biotech and Medical Device industries
  • Hospitals, Labs & Associations
  • Horticulture specialists
  • Farm technicians
  • Hydroponics Growers
  • Environmental specialists

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, investors, scientists who are related to Microbiome, Nutrition. Pathologists, Doctors, Director and Managers from business organizations.

Benefits of attending Microbiome Conference?

  • An opportunity to meet the mentors across the world.
  • To share the knowledge with doctors and Scientists.
  • B2B Meetings.
  • Meet the experts in the field of Microbiome.   
  • To gain advanced knowledge in Microbiome.
  • To meet investors from a different sector of Healthcare.
  • To develop collaborations between Academic and Business. 



Sessions and Tracks

Track 1: Microbiome

A microbiota is an "ecological community of commensal, symbiotic and pathogenic microorganisms found in and on all multicellular organisms studied to date from plants to animals. A microbiota includes bacteria, archaea, protists, fungi and viruses. Microbiota have been found to be crucial for immunologic, hormonal and metabolic homeostasis of their host.

The human microbiome may play a role in the activation of toll-like receptors in the intestines, a type of pattern recognition receptor host cells use to recognize dangers and repair damage. Pathogens can influence this coexistence leading to immune dysregulation including and susceptibility to diseases, mechanisms of inflammation, immune tolerance, and autoimmune diseases.

Track 2: Human Microbiota

The human microbiome refers specifically to the collective genomes of resident microorganisms. The skin and mucous membranes always harbor a variety of microorganisms that can be arranged into two groups: (1) the resident microbiota consists of relatively fixed types of microorganisms regularly found in a given area at a given age; if disturbed, it promptly reestablishes itself; and (2) the transient microbiota consists of nonpathogenic or potentially pathogenic microorganisms that inhabit the skin or mucous membranes for hours, days, or weeks. The transient microbiota is derived from the environment, does not produce disease.

Track 3: Prebiotics and Probiotics   

Prebiotics and probiotics both support the body in building and maintaining a healthy colony of bacteria and other microorganisms, which supports the gut and aids digestion. These food components help promote beneficial bacteria by providing food and creating an environment where microorganisms can flourish. Prebiotics are present in fiber-rich foods, such as fruits, vegetables, and whole grains. Probiotics occur in many fermented foods, including yogurt, sauerkraut, and tempeh.

Track 4: Gut Microbiota

Gut flora, or gut microbiota, or gastrointestinal microbiota, is the complex community of microorganisms that live in the digestive tracts of humans and animals, including insects. The gut metagenome is the aggregate of all the genomes of gut microbiota. The relationship between some gut flora and humans is not merely commensal (a non-harmful coexistence), but rather a mutualistic relationship. An enterotype is a classification of living organisms based on its bacteriological ecosystem in the human gut microbiome. The gut microbiota plays a key role in digestion, metabolism and immune function, and has a widespread impact beyond the gastrointestinal tract. Changes in the biodiversity of the gut microbiota are associated with far-reaching consequences on host health and development. Diet, functional foods, and gut microbiota transplantation are areas that have yielded some therapeutic success in modulating the gut microbiota and warrant further investigation of their effects on various disease states.

The four dominant bacterial phyla in the human gut are:

  1. Firmicutes
  2. Bacteroidetes
  3. Actinobacteria
  4. Proteobacteria


Small intestine bacterial overgrowth (SIBO), also termed bacterial overgrowths, or small bowel bacterial overgrowth syndrome (SBBOS), is a disorder of excessive bacterial growth in the small intestine. Patients with bacterial overgrowth that is longstanding can develop complications of their illness as a result of malabsorption of nutrients. Anemia may occur from a variety of mechanisms, as many of the nutrients involved in production of red blood cells are absorbed in the affected small bowel. Probiotics are bacterial preparations that alter the bacterial flora in the bowel to cause a beneficial effect. Animal research has demonstrated that probiotics have barrier enhancing, antibacterial, immune modulating and anti-inflammatory effects which may have a positive effect in the management of SIBO in humans. 

Track 6: Host-Microbe Biology (HMB)

Host-Microbe interactions are the collaborations occurring between a pathogen (e.g. infection, microscopic organisms) and their host (e.g. people, plants). The host-pathogen interface presents intriguing cell changes perceptible under electron microscope - occurrence to the pathogens for upgraded harmfulness, including arrangement of surface "invasosomal" periplasmic organelles and exocytosis of bacterial external film vesicles by gram-negative pathogens. Host cell cytoskeletal reorganizational changes e.g., unsettle development, adjusted phagocytosis; and so on additionally occur as a prelude to microbial attack.

Host-Microbe Biology includes

  • Genetic and Physiological Adaptation to the Host
  • Host Response to Microbes
  • Cellular/Molecular Host-Microbe Interactions
  • Invasion and Survival in Host Cells
  • Manipulations of Host Functions by Microbes
  • Microbe-Plant Interactions
  • Microbiome-Host Interactions
  • Phage-Host Interactions
  • Sepsis and Inflammation
  • Surface Structures of Pathogenic Microbes
  • Toxins and Secreted Factors
  • Virulence Regulatory Mechanisms
  • Virus-Host Interactions
  • Microbial Metabolism and Host Association
  • Anti-pathogen Strategies

Microbial ecology (or environmental microbiology) is the ecology of microorganisms: their relationship with one another and with their environment. It concerns the three major domains of life—Eukaryota,  Archaea, and Bacteria—as well as viruses. Microorganisms are the backbone of all ecosystems, but even more so in the zones where photosynthesis is unable to take place because of the absence of light. In such zones, chemosynthetic microbes provide energy and carbon to the other organisms. 

Plant growth-promoting bacteria (PGPB) occupy the rhizosphere of many plant species and have beneficial effects on the host plant. They may influence the plant in a direct or indirect manner. A direct mechanism would be to increase plant growth by supplying the plant with nutrients and hormones; Indirect mechanisms on the otherhand, include, reduced susceptibility to diseases, and activating a form of defense referred to as induced systematic resistance. Soil microorganisms are the most abundant of all the biota in soil and responsible for driving nutrient and organic matter cycling, soil fertility, soil restoration, plant health and ecosystem primary production. Beneficial microorganisms include those that create symbiotic associations with plant roots like rhizobia, mycorrhizal fungi, actinomycetes, diazotrophic bacteria, promote nutrient mineralization and availability, produce plant growth hormones, and are antagonists of plant pests, parasites or diseases. Many of these organisms are already naturally present in the soil, although in some situations it may be beneficial to increase their populations by either inoculation or by applying various agricultural management techniques that enhance their abundance and activity.

There are two ways by which a baby can come into this world: vaginally or by Cesarean delivery.   The vast majority of our critical gut microbiome bacteria from our mothers during birth and breastfeeding. The method of delivery impacts the baby’s microbiome, with vaginal delivery (VD) having a strong, beneficial effect and cesarean delivery (CD) reducing the number and diversity of beneficial bacteria.  Cesarean delivery poses a health risk for newborns by way of changes in the gut microbiota there microbial species or genera that are uniformly present in all vaginally delivered infants and uniformly absent in all Cesareanā€born. The infant’s gut microbiome is of critical importance since its bacteria build and strengthen baby’s immune system. The microbiomes of babies born via vaginal delivery (VD) and via cesarean delivery (CD) are different, due to the different microbiomes they are receiving from their mother and their physical environment, during a vaginal birth, the baby receives maternal vaginal, intestinal and fecal bacteria present in the birth canal; these bacteria are augmented with bacteria from mother’s skin, oral and breast milk microbiomes through holding, kissing and breastfeeding. Scientists speculate this may account for the increased long-term risk and incidence of chronic, non-communicable diseases (including allergies, asthma, obesity and autoimmune diseases) among babies born via cesarean section.


Microbiology Societies

  • International Union of Microbiological Societies (IUMS)
  • International Society for Antiviral Research (ISAR)
  • International Society for Microbial Ecology (ISME)
  • International Society for NeuroVirology (ISNV)
  • International Society of Chemotherapy Infection and Cancer (ISC)
  • Federation of European Microbiological Societies (FEMS)
  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • European Molecular Biology Organization (EMBO)
  • European Mycological Association
  • European Society for Clinical Virology (ESCV)
  • European Meningococcal Disease Society (EMGM)
  • Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG)
  • Belgian Society for Microbiology
  • Belgian Society of Infectious Diseases and Clinical Microbiology (SBIMC-BVIKM)
  • Danmarks Mikrobiologiske Selskab (Danish Microbiological Society)
  • Danish Infectious Disease Society
  • Danish Society for Clinical Microbiology
  • Societas Biochemica, Biophysica et Microbiologica Fenniae
  • Finnish Society for the Study of Infectious Diseases
  • Societe Francaise de Microbiologie (French Society for Microbiology, SFM)


Past Conference Report

Microbiome 2019

Conference series LLC LTD hosted the “3rd Microbiome, Probiotics & Gut Nutrition” during December 06-07, 2019 at  Vancouver, Canada with the theme “Current Research on Microbiomes, probiotics and Gut Nutrition” was a great success, where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Microbiologists, Scientists, Researchers, Students and Leaders in Probiotics research, Gut Nutrition related research field, Immunology, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

The conference was embarked with an opening ceremony followed by a series of lectures delivered by Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Dr. Shrilakshmi Desiraju, Triphase Pharmaceuticals Pvt.Ltd., India
  • Deanna L. Gibson, The University of British Columbia, Canada
  • Dr. Ivana Haluskova Balter, French Immunology Society, France
  • A R M Solaiman, Bangabandhu Sheikh Mujibur Rahman Agricultural University, Bangladesh

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Shrilakshmi Desiraju, for  her remarkable contribution towards smooth functioning at Microbiome-2019 Conference.

Conference Sessions Chairs:

  • Dr. Ivana Haluskova Balter, French Immunology Society, France

Conference Poster Judge:

  • Dr. Ivana Haluskova Balter, French Immunology Society, France

Conference Series LLC LTD offers its heartfelt appreciation to Societies and Organizations includes Event Brite, All Events, Gov EventsCrowd ReviewsPharmaceutical OnlineBio Events, Pharma Voice and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC LTD in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Microbiome 2020, Conference Series LLC LTD is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, Microbiome 2020 to be held during December 07-08, 2020 Vancouver, Canada.


                                      Let us meet again @ Microbiome 2020

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date December 07-08, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner